NO20002314D0 - Nye 2,3-metano-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem - Google Patents
Nye 2,3-metano-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende demInfo
- Publication number
- NO20002314D0 NO20002314D0 NO20002314A NO20002314A NO20002314D0 NO 20002314 D0 NO20002314 D0 NO 20002314D0 NO 20002314 A NO20002314 A NO 20002314A NO 20002314 A NO20002314 A NO 20002314A NO 20002314 D0 NO20002314 D0 NO 20002314D0
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- alkyl
- new
- preparation
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905601A FR2793248B1 (fr) | 1999-05-03 | 1999-05-03 | Nouveaux derives de 2,3-methano-aminoacides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20002314D0 true NO20002314D0 (no) | 2000-05-02 |
NO20002314L NO20002314L (no) | 2000-11-06 |
Family
ID=9545154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20002314A NO20002314L (no) | 1999-05-03 | 2000-05-02 | Nye 2,3-metano-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem |
Country Status (23)
Country | Link |
---|---|
US (1) | US6288077B1 (no) |
EP (1) | EP1050534B1 (no) |
JP (1) | JP3200053B2 (no) |
KR (1) | KR100439599B1 (no) |
CN (1) | CN1130347C (no) |
AT (1) | ATE210131T1 (no) |
AU (1) | AU763670B2 (no) |
BR (1) | BR0002075A (no) |
CA (1) | CA2308780C (no) |
DE (1) | DE60000036T2 (no) |
DK (1) | DK1050534T3 (no) |
EA (1) | EA002645B1 (no) |
ES (1) | ES2169716T3 (no) |
FR (1) | FR2793248B1 (no) |
HK (1) | HK1032237A1 (no) |
HU (1) | HUP0001712A3 (no) |
MX (1) | MXPA00004241A (no) |
NO (1) | NO20002314L (no) |
NZ (1) | NZ504298A (no) |
PL (1) | PL198571B1 (no) |
PT (1) | PT1050534E (no) |
SI (1) | SI1050534T1 (no) |
ZA (1) | ZA200002152B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774110B2 (en) * | 2001-03-19 | 2004-08-10 | Lg Life Sciences Ltd. | Orally available peptidic thrombin inhibitors |
JP2003072059A (ja) * | 2001-06-21 | 2003-03-12 | Ricoh Co Ltd | インクジェット記録装置及び複写機 |
TW200911787A (en) * | 2007-07-03 | 2009-03-16 | Astrazeneca Ab | New aza-bicyclohexane compounds useful as inhibitors of thrombin |
EP2321301A4 (en) * | 2008-06-23 | 2011-09-28 | Astrazeneca Ab | NOVEL HETEROCYCLIC CARBOXAMIDES AS THROMBIN INHIBITORS |
CN116813691B (zh) * | 2018-10-29 | 2024-04-12 | 丽珠医药集团股份有限公司 | 新的二肽类化合物及其用途 |
WO2024015574A1 (en) * | 2022-07-14 | 2024-01-18 | Jnana Therapeutics Inc. | Small molecule inhibitors of mammalian slc6a19 function |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954158A (en) * | 1983-08-16 | 1990-09-04 | University Of Georgia Research Foundation, Inc. | 2,3-methanoproline |
FR2701951B1 (fr) * | 1993-02-24 | 1995-06-09 | Adir | Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
US5688826A (en) * | 1995-11-16 | 1997-11-18 | Eli Lilly And Company | Excitatory amino acid derivatives |
NO310618B1 (no) * | 1997-04-10 | 2001-07-30 | Ono Pharmaceutical Co | Kondenserte piperidinforbindelser, fremstilling og anvendelse derav, samt preparater omfattende slike forbindelser |
-
1999
- 1999-05-03 FR FR9905601A patent/FR2793248B1/fr not_active Expired - Fee Related
-
2000
- 2000-04-27 EA EA200000374A patent/EA002645B1/ru not_active IP Right Cessation
- 2000-04-28 PL PL339967A patent/PL198571B1/pl unknown
- 2000-04-30 CN CN00119227A patent/CN1130347C/zh not_active Expired - Fee Related
- 2000-05-02 DK DK00401197T patent/DK1050534T3/da active
- 2000-05-02 EP EP00401197A patent/EP1050534B1/fr not_active Expired - Lifetime
- 2000-05-02 MX MXPA00004241A patent/MXPA00004241A/es active IP Right Grant
- 2000-05-02 PT PT00401197T patent/PT1050534E/pt unknown
- 2000-05-02 HU HU0001712A patent/HUP0001712A3/hu unknown
- 2000-05-02 US US09/561,618 patent/US6288077B1/en not_active Expired - Fee Related
- 2000-05-02 NZ NZ504298A patent/NZ504298A/xx unknown
- 2000-05-02 SI SI200030004T patent/SI1050534T1/xx unknown
- 2000-05-02 AT AT00401197T patent/ATE210131T1/de not_active IP Right Cessation
- 2000-05-02 ES ES00401197T patent/ES2169716T3/es not_active Expired - Lifetime
- 2000-05-02 DE DE60000036T patent/DE60000036T2/de not_active Expired - Fee Related
- 2000-05-02 NO NO20002314A patent/NO20002314L/no not_active Application Discontinuation
- 2000-05-03 CA CA002308780A patent/CA2308780C/fr not_active Expired - Fee Related
- 2000-05-03 AU AU31325/00A patent/AU763670B2/en not_active Ceased
- 2000-05-03 BR BR0002075-3A patent/BR0002075A/pt not_active Application Discontinuation
- 2000-05-03 KR KR10-2000-0023669A patent/KR100439599B1/ko not_active IP Right Cessation
- 2000-05-03 ZA ZA200002152A patent/ZA200002152B/xx unknown
- 2000-05-08 JP JP2000134144A patent/JP3200053B2/ja not_active Expired - Fee Related
-
2001
- 2001-04-23 HK HK01102869A patent/HK1032237A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
BRPI0211844B8 (pt) | composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica | |
DE69820248D1 (de) | Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben | |
NO20085077L (no) | Nye forbindelser | |
EP1400518A4 (en) | DERIVATIVES OF HETEROCYCLIC COMPOUNDS AND MEDICINAL PRODUCTS | |
NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
CA2336412A1 (en) | Medicament for treatment of diabetes | |
EP1396493A4 (en) | HETEROCYCLIC COMPOUNDS | |
NO20025035D0 (no) | Oksadiazolderivater som har anticancer-effekter | |
NO20022552D0 (no) | Nye benzotiadiazinderivater, deres fremstilling og farmasöytiske sammensetninger inneholdende det samme | |
PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
NO20002314L (no) | Nye 2,3-metano-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
EP1553096A4 (en) | pyrazole | |
NO20055844D0 (no) | Nye benzotiazin og benzotiadiazinforbindelsep fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
IL169577A0 (en) | Oligosaccharide derivatives and pharmaceutical compostions containing the same | |
NO20026004D0 (no) | Nye podofyllotoksinkarbamat- og tiokarbamatforbindelser, fremgangsmåte vedderes fremstilling og farmasöytiske sammensetninger inneholdendedem | |
ATE323484T1 (de) | Neue pharmazeutische verbindungen mit alpha2receptor aktivität | |
EA200400667A2 (ru) | Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат | |
IL36404A (en) | N-(substituted methyl)-n'-phenylformamidine derivatives and compositions containing them | |
DE60238847D1 (de) | Pyrimidinderivate enthaltendes medikament | |
DK0611755T3 (da) | Hidtil ukendte (cyklohexyl)alkenforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
IL44230A (en) | 3-substituted-1-(4-(2-(4-methyl-5-thiazolecarboxamido)-ethyl) benzenesulfonyl)urea derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |